Prognostic Association of Prostate-specific Antigen Decline with Clinical Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide in a Randomized Clinical Trial

Authors: Armstrong, Andrew J., Lin, Ping, Higano, Celestia S., Iversen, Peter, Sternberg, Cora N., Tombal, Bertrand, Phung, De, Parli, Teresa, Krivoshik, Andrew, Beer, Tomasz M.

Source: In European Urology Oncology November 2019 2(6):677-684

Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results

Authors: Tombal, Bertrand, Borre, Michael, Rathenborg, Per, Werbrouck, Patrick, Van Poppel, Hendrik, Heidenreich, Axel, Iversen, Peter, Braeckman, Johan, Heracek, Jiri, Baron, Benoit, Krivoshik, Andrew, Hirmand, Mohammad, Smith, Matthew R.

Source: In The Journal of Urology February 2018 199(2):459-464

Clinical Outcomes of Chemotherapy Naïve Men with Metastatic Castration Resistant Prostate Cancer and Low Baseline Prostate Specific Antigen Treated with Enzalutamide vs Placebo

Authors: Taplin, Mary-Ellen, Armstrong, Andrew J., Lin, Ping, Krivoshik, Andrew, Phung, De, Parli, Teresa, Tombal, Bertrand, Beer, Tomasz M.

Source: In The Journal of Urology December 2017 198(6):1324-1332

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

Authors: Wilson, Wyndham H, O'Connor, Owen A, Czuczman, Myron S, LaCasce, Ann S, Gerecitano, John F, Leonard, John P, Tulpule, Anil, Dunleavy, Kieron, Xiong, Hao, Chiu, Yi-Lin, Cui, Yue, Busman, Todd, Elmore, Steven W, Rosenberg, Saul H, Krivoshik, Andrew P, Enschede, Sari H, Humerickhouse, Rod A

Source: In Lancet Oncology 2010 11(12):1149-1159

O1-9-2 - Phase I / II study of ASP8273 in patients with non-small-cell lung cancer (NSCLC) harboring EGFR activating mutations

Authors: Shimizu, Toshio, Nokihara, Hiroshi, Murakami, Haruyasu, Seto, Takashi, Nishio, Makoto, Takeda, Koji, Inoue, Akira, Kiura, Katsuyuki, Azuma, Koichi, Keating, Anne, Krivoshik, Andrew, Uegaki, Koichi, Takeda, Kentaro, Komatsu, Kanji, Morita, Satoshi, Fukuoka, Masahiro, Nakagawa, Kazuhiko

Source: In Annals of Oncology November 2015 26 Supplement 7:vii82-vii82

METHOD OF TREATING CANCER

Force relaxes before the fall of cytosolic calcium in the photomechanical response of rat sphincter pupillae.

Authors: Krivoshik, Andrew P., Barr, Lloyd

Source: American Journal of Physiology; July 2000 pt1, Vol. 279 Issue 1, pC274-C280, 7p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

PD10-09 THE PROSPER TRIAL: CHEMOTHERAPY-RELATED ENDPOINTS IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER TREATED WITH ENZALUTAMIDE

Authors: Shore, Neal, Saad, Fred, Hussain, Maha, Fizazi, Karim, Rathenborg, Per, Demirhan, Eren, Modelska, Katharina, Phung, De, Krivoshik, Andrew, Sternberg, Cora N.

Source: In The Journal of Urology April 2018 199(4) Supplement:e231-e231

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.